The Future of AI Design in Medical Devices can you find references and pros and cons on using this topic in a dissertation

Argument (concise) The proposed dissertation topic is important but currently overbroad and vulnerable to several substantive problems that can undermine its scholarly and practical contribution. Left unfocused, it risks producing a descriptive overview rather than an original, defensible argument or replicable empirical findings. Key objections 1. Epistemic diffusion and lack of focus - Covering algorithmic design, human–device interaction, regulation, ethics, and socioeconomics simultaneously makes it hard to develop a clear, testable research question or deep contribution. The work may become a literature summary instead of producing novel theory or evidence (Popper, The Logic of Scientific Discovery). 2. Rapid obsolescence - AI methods and regulatory regimes (FDA AI/ML plans, EU AI Act) evolve quickly. Broad claims about "the future" can be overtaken during a typical multi‑year doctoral program, reducing long‑term impact. 3. Data access and reproducibility limits - Many deployed AI medical-device models and datasets are proprietary. Without partnerships or open data, empirical claims will be hard to verify or reproduce (Ghassemi et al., Lancet Digital Health, 2021). 4. Validation and methodological complexity - Demonstrating safety, generalizability, and robustness for adaptive/continuous‑learning systems is technically and ethically challenging; doing so credibly often requires large-scale clinical validation beyond most doctoral resources. 5. Interdisciplinary overstretch - Adequately addressing technical, clinical, legal, and ethical dimensions demands supervisory breadth and researcher expertise that may exceed what a single dissertation can sustainably deliver. This raises the risk of superficial treatment across domains. 6. Normative and policy ambiguities - Prescriptive regulatory or ethical recommendations presuppose contested value trade-offs (safety vs. innovation; equity vs. efficiency). Without an explicit normative framework, guidance may lack justification or practical uptake (Floridi et al., AI4People, 2018). Concise recommendations (mitigation) - Narrow scope: choose a device class (e.g., imaging SaMD), a specific technical problem (validation of continuous‑learning models), or a single jurisdiction (FDA or EU). - Aim for a tractable contribution: a methodological protocol, a case study with partnered data, or a normative framework applied to a concrete policy question. - Secure collaborations early: clinical or industry partners to access data and realistic constraints. - Frame findings as contingent and include a short "living" review section to track regulatory/technical updates. Selected supporting references - U.S. FDA. "Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan." 2021. https://www.fda.gov/media/145022/download - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Wiens, J., et al. "Do no harm: a roadmap for responsible machine learning for health care." Nature Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - Popper, K. "The Logic of Scientific Discovery." 1959. If you’d like, ITitle can: A convert Short this Crit critiqueique into a of one "‑Thepage Future document of for AI your Design proposal in and Medical propose Devices three — narrow alternative Pros dissertation, questions Cons (with, brief and outlines Key) References tailored to" feasibilityArgument ( andconc impact.ise) Although the topic is timely and important, as framed it is too broad and vulnerable to substantive weaknesses that can undermine a dissertation’s originality, rigor, and long‑term impact. 1. Diffuse scope and weak causal claim - Covering algorithm design, human–device interaction, regulation, ethics, and socio‑economics risks producing a descriptive overview rather than an analytically deep, falsifiable contribution. Fewer, sharper research questions yield clearer theoretical and empirical advances (cf. Popper, The Logic of Scientific Discovery). 2. Rapid obsolescence - AI methods, commercial products, and regulatory frameworks (FDA guidance, EU AI Act drafts) change rapidly. Broad claims about “the future” may be overtaken by events before completion, reducing scholarly and policy relevance. 3. Empirical and reproducibility limits - Leading AI medical devices and datasets are often proprietary. Without industry partnerships or well‑chosen open datasets, empirical work will be constrained and hard to reproduce (Ghassemi et al., Lancet Digital Health, 2021). 4. Validation and generalizability problems - Key technical challenges—distribution shift, bias, continuous learning—are hard to evaluate convincingly within typical doctoral resource limits. Short‑term lab studies or retrospective validations may not generalize to clinical practice (Kelly et al., BMC Medicine, 2019). 5. Interdisciplinary overreach and supervisory burden - The required depth across machine learning, clinical science, regulatory law, human factors, and ethics can exceed a single student’s time and supervisory expertise; this risks superficial treatment of central issues. 6. Normative ambiguity - Policy or ethical recommendations presuppose contested value tradeoffs (safety vs. innovation, equity vs. efficiency). Without an explicit normative framework, recommendations may appear arbitrary or lack persuasive grounding (Floridi et al., AI4People, 2018). Practical consequence Left un-narrowed, the project is likely to yield a useful literature review but less likely to deliver a distinctive theoretical contribution, robust empirical findings, or actionable policy prescriptions. Recommended fix (brief) - Narrow to a tractable, high‑impact question (e.g., continuous‑learning imaging SaMD under FDA/EU frameworks; clinician-facing explainability in radiology tools). - Choose a concrete case study or methodological contribution (validation protocol, evaluation metrics). - Secure partnerships or open datasets to ensure reproducible empirical work. - Ground policy recommendations in an explicit normative framework. Key sources cited - Popper, K. R. The Logic of Scientific Discovery. 1959. - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health-care data." Lancet Digital Health, 2021. - Kelly, C. J., et al. "Key challenges for delivering clinical impact with artificial intelligence." BMC Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - FDA. "AI/ML-Based SaMD Action Plan." 2021. https://www.fda.gov/media/145022/download If you want, I can convert this critique into a one‑page proposal amendment or suggest three narrowly focused alternative dissertation questions and a brief chapter outline.Title: A Short Critique of "The Future of AI Design in Medical Devices — Pros, Cons, and Key References" Argument (concise) Although the proposed dissertation topic is timely and societally important, as stated it is overly broad and faces structural limits that threaten its originality, empirical rigor, and lasting scholarly impact. The central risks are conceptual diffusion, empirical intractability, and rapid obsolescence. Without careful narrowing, the project is likely to produce a descriptive overview rather than a focused, testable contribution. Key objections 1. Lack of focus and theory - The topic spans algorithm design, human–device interaction, regulation, ethics, and socioeconomics. That breadth risks superficial treatment and weak theoretical contribution. Strong dissertations typically center on a precise research question or hypothesis (see Popper, The Logic of Scientific Discovery, 1959). 2. Rapid obsolescence - AI methods and regulatory frameworks (FDA AI/ML action plans, EU AI Act drafts) evolve quickly. Broad claims about “the future” can become outdated over the course of a multi‑year thesis, reducing long‑term relevance. 3. Data and reproducibility constraints - Leading AI medical-device systems and datasets are often proprietary. Limited access impedes reproducible experiments and independent verification, undermining empirical credibility (Ghassemi et al., Lancet Digital Health, 2021). 4. Validation and generalizability problems - Demonstrating clinical safety across distribution shifts, demographic diversity, and real‑world workflows is technically and ethically complex. Broad studies may not meet the evidentiary standard required to substantiate claims about safety or efficacy (Wiens et al., Nature Medicine, 2019). 5. Supervisory and methodological overreach - Addressing the full scope demands deep expertise across machine learning, clinical medicine, human factors, and regulatory law. Without interdisciplinary supervisory capacity, the work risks being uneven or underdeveloped in key areas. 6. Normative ambiguity and limited policy traction - Policy and ethical recommendations require settling value trade‑offs (safety vs. innovation vs. access). Broad, jurisdiction‑spanning recommendations may be too general to guide specific regulatory decisions or engineering practices (Floridi et al., AI4People, 2018). Concise recommendations (mitigation) - Narrow the scope: pick one device class (e.g., imaging SaMD), one problem (e.g., validation of continuous‑learning systems), or one jurisdiction (FDA or EU). - Emphasize a methodological or conceptual contribution (e.g., a validation protocol, accountability framework) rather than broad futurism. - Secure partnerships with clinical or industry collaborators to access data and practical constraints. - Frame findings as context‑specific and include a “living appendix” for regulatory updates. Selected references supporting the critique - U.S. Food & Drug Administration. "Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan." 2021. https://www.fda.gov/media/145022/download - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Wiens, J., et al. "Do no harm: a roadmap for responsible machine learning for health care." Nature Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - Popper, K. R. "The Logic of Scientific Discovery." 1959. If you’d like, I can turn this critique into a one‑page proposal revision: a narrowed research question, a three‑chapter outline, and recommended data sources.